Pharmaceutical News

RSS

FDA accepts Orexigen's Contrave NDA for treatment of obesity

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.

2 Jun 2010

Over-the-counter supplements can cause hypertension and kidney failure

Negative health effects linked to taking too much supplemental calcium are on the rise, according to a commentary appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

2 Jun 2010

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.

2 Jun 2010

Teva Pharmaceutical launches Gianvi Tablets

Teva Pharmaceutical Industries Ltd. announced today that it has commercially launched Gianvi (Drospirenone and Ethinyl Estradiol) Tablets, the Company's generic version of Bayer's Yaz® Tablets.

2 Jun 2010

FDA approves Prolia for postmenopausal women with osteoporosis

The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.

2 Jun 2010

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin.

2 Jun 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN from June 30 - July 2, 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN, organised by Reed Exhibitions Japan, will come back again as Asia's largest bio-event from June 30 - July 2, 2010. One of the hottest feature topics is "antibody drugs".

1 Jun 2010

OroScience signs agreement with ACE Surgical Supply to market Periogenix periodontal wound dressing

OroScience plc (Palo Alto, CA), an oral care life science company, announced today that it has entered into an agreement with ACE Surgical Supply, Inc. (Brockton, MA) to market and distribute Periogenix periodontal wound dressing to clinicians in the United States and Canadian dental markets.

1 Jun 2010

Sticky gel composed of MPEG-pDHA may help seal wounds created by surgery: Study

A compound found in sunless tanning spray may help to heal wounds following surgery, according to new results published by plastic surgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City and biomedical engineers at Cornell University in Ithaca, N.Y., where the novel compound was developed.

1 Jun 2010

More insight into key receptor that influences effectiveness of serotonin-related antidepressants

University of Michigan scientists have provided the most detailed picture yet of a key receptor in the brain that influences the effectiveness of serotonin-related antidepressants, such as Prozac.

1 Jun 2010

EpiCept provides update on post-approval commitments requested by EMA for Ceplene

EpiCept Corporation today provided an update on the post-approval commitments requested by the European Medicines Agency as part of its marketing authorization for Ceplene (histamine dihydrochloride). Ceplene is approved in the EU for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia in first complete remission.

1 Jun 2010

New study finds usage of antidepressants increases risk of miscarriage in pregnant women

A new study in CMAJ (Canadian Medical Association Journal) found a 68% increase in the overall risk of miscarriage in pregnant women using antidepressants.

1 Jun 2010

Ubichem Research receives approval for supply of cGMP radiolabelled APIs

Ubichem, a leading provider of chemistry services to the drug development sector, through its Hungarian operation - Ubichem Research - has successfully completed a regulatory inspection and is now approved for the supply of cGMP radiolabelled Active Pharmaceutical Ingredients (APIs).

31 May 2010

BPC mobilizes to ensure patient interests are put first in new BC PharmaCare drug review process

On the verge of a BC Government announcement on a new policy on generic medication pricing and a Long Term Pharmacy Agreement, the Better Pharmacare Coalition (BPC) is mobilizing its two million members to ensure Government keeps its promise that patient interests and input are reflected in the new BC PharmaCare drug review process.

31 May 2010

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

29 May 2010

NSF International tests, certifies nutritional supplements to prevent unacceptable contaminants

Recent news coverage has consumers concerned about the alarming amount of contaminants, such as pesticides and heavy metals, being found in herbal supplements. NSF International, an independent, not-for-profit public health organization, helps ease these concerns by testing and certifying supplements to ensure they are free of undeclared substances and unacceptable contaminants.

29 May 2010

Teva invests £37 million to expand Ontario production plant

The world's largest generic pharmaceutical company is investing £37 million to expand its Stouffville, Ontario production plant.

29 May 2010

Researchers assess effects of statins on tendon rupture

Michigan State University researchers are studying the role that statins - lifesavers for tens of millions of Americans trying to lower their cholesterol - play in causing disabling tendon ruptures.

29 May 2010

Research to understand potential role of sexual lubricants in HIV transmission

Today at the 2010 International Microbicides Conference in Pittsburgh, Dezzutti presented the results of tests conducted with five of the most widely used lubricants, chosen from the results of an IRMA web-based survey that collected information on the lubricant preferences of nearly 9,000 men and women from over 100 countries. Dezzutti's findings indicated that some of the products studied had toxic effects on cells and rectal tissue.

29 May 2010

HUYA Bioscience International forms strategic partnership with School of Chinese Materia Medica of BUCM

HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovation, today announced a strategic partnership with the School of Chinese Materia Medica of the Beijing University of Chinese Medicine (BUCM). As one of a series of collaborations that HUYA has established with China's leading research and development institutions, the agreement demonstrates HUYA's visionary commitment to enabling and accelerating the global development and commercialization of novel biopharmaceutical products originating in China.

29 May 2010

Pharmaceutical News

FDA accepts Orexigen's Contrave NDA for treatment of obesity

Over-the-counter supplements can cause hypertension and kidney failure

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Teva Pharmaceutical launches Gianvi Tablets

FDA approves Prolia for postmenopausal women with osteoporosis

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

9th INT'L BIO FORUM & BIO EXPO JAPAN from June 30 - July 2, 2010

OroScience signs agreement with ACE Surgical Supply to market Periogenix periodontal wound dressing

Sticky gel composed of MPEG-pDHA may help seal wounds created by surgery: Study

More insight into key receptor that influences effectiveness of serotonin-related antidepressants

EpiCept provides update on post-approval commitments requested by EMA for Ceplene

New study finds usage of antidepressants increases risk of miscarriage in pregnant women

Ubichem Research receives approval for supply of cGMP radiolabelled APIs

BPC mobilizes to ensure patient interests are put first in new BC PharmaCare drug review process

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

NSF International tests, certifies nutritional supplements to prevent unacceptable contaminants

Teva invests £37 million to expand Ontario production plant

Researchers assess effects of statins on tendon rupture

Research to understand potential role of sexual lubricants in HIV transmission

HUYA Bioscience International forms strategic partnership with School of Chinese Materia Medica of BUCM

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News